blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3519049

EP3519049 - SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL23 SPECIFIC ANTIBODY [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  10.03.2023
Database last updated on 16.09.2024
FormerRequest for examination was made
Status updated on  05.07.2019
FormerThe international publication has been made
Status updated on  07.04.2018
Most recent event   Tooltip13.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Janssen Biotech, Inc.
800/850 Ridgeview Drive
Horsham, PA 19044 / US
[2019/32]
Inventor(s)01 / RANDAZZO, Bruce
1400 McKean Road
Spring House Pennsylvania 19477 / US
02 / WASFI, Yasmine
1400 McKean Road
Spring House Pennsylvania 19477 / US
 [2019/32]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2019/32]Wise, Daniel Joseph
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
Application number, filing date17857471.129.09.2017
[2019/32]
WO2017US54217
Priority number, dateUS201662402403P30.09.2016         Original published format: US 201662402403 P
US201762532068P13.07.2017         Original published format: US 201762532068 P
[2019/32]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018064436
Date:05.04.2018
Language:EN
[2018/14]
Type: A1 Application with search report 
No.:EP3519049
Date:07.08.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 05.04.2018 takes the place of the publication of the European patent application.
[2019/32]
Search report(s)International search report - published on:US05.04.2018
(Supplementary) European search report - dispatched on:EP28.04.2020
ClassificationIPC:C07K16/24, A61P25/00, A61P37/00
[2020/22]
CPC:
C07K16/244 (EP,KR,US); A61K39/3955 (US); A61K45/06 (EP,US);
A61P17/06 (EP,KR,US); C07K16/241 (EP,US); A61K2039/505 (EP,KR,US);
A61K2039/54 (EP,US); A61K2039/545 (EP,US); C07K2317/21 (EP,US);
C07K2317/56 (US); C07K2317/565 (KR,US) (-)
Former IPC [2019/32]A61P25/00, A61P37/00, C07K16/24
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/32]
Extension statesBA30.04.2019
ME30.04.2019
Validation statesMA30.04.2019
MD30.04.2019
TitleGerman:SICHERES UND EFFIZIENTES VERFAHREN ZUR BEHANDLUNG VON PSORIASIS MIT ANTI-IL23-SPEZIFISCHEM ANTIKÖRPER[2019/32]
English:SAFE AND EFFECTIVE METHOD OF TREATING PSORIASIS WITH ANTI-IL23 SPECIFIC ANTIBODY[2019/32]
French:PROCÉDÉ SÛR ET EFFICACE DE TRAITEMENT DU PSORIASIS AVEC UN ANTICORPS SPÉCIFIQUE CONTRE L'IL-23[2019/32]
Entry into regional phase30.04.2019National basic fee paid 
30.04.2019Search fee paid 
30.04.2019Designation fee(s) paid 
30.04.2019Examination fee paid 
Examination procedure30.04.2019Examination requested  [2019/32]
25.11.2020Amendment by applicant (claims and/or description)
14.03.2023Despatch of a communication from the examining division (Time limit: M04)
24.07.2023Reply to a communication from the examining division
Fees paidRenewal fee
13.09.2019Renewal fee patent year 03
14.09.2020Renewal fee patent year 04
11.09.2021Renewal fee patent year 05
16.08.2022Renewal fee patent year 06
24.08.2023Renewal fee patent year 07
13.08.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[E]WO2018093841  (JANSSEN BIOTECH INC [US]);
International search[Y]US2009181027  (DAL MONTE PAUL [US], et al);
 [XY]US2011287028  (BENSON JACQUELINE [US], et al);
 [Y]US2015147337  (REICHERT PAUL [US], et al);
 [Y]WO2016031250  (KIRIN AMGEN INC [US], et al);
 [Y]US2016222102  (ARNDT MATTHIAS [DE], et al)
by applicantEP0003089
 US4309989
 US4399216
 US4589330
 WO8605803
 US4634665
 US4656134
 US4676980
 EP0229046
 EP0229246
 US4683195
 US4683202
 US4704692
 US4766067
 US4767402
 WO8806630
 US4795699
 US4800159
 US4816567
 US4818542
 WO8906283
 US4873316
 US4889818
 WO9003809
 WO9004036
 US4921794
 EP0368684
 EP0371998
 US4939666
 US4946778
 US4956288
 US4965188
 WO9014443
 WO9014424
 WO9014430
 WO9100360
 US4994370
 WO9105939
 WO9109630
 WO9117271
 US5066584
 WO9118980
 WO9119818
 WO9200373
 US5091310
 WO9205258
 US5122464
 US5130238
 US5142033
 WO9214843
 US5149636
 WO9216221
 WO9218619
 US5168062
 US5179017
 WO9308278
 WO9308829
 US5223409
 US5225539
 EP0550400
 US5260203
 US5266491
 WO9401234
 EP0590689
 US5304489
 GB2272440
 WO9425585
 US5385839
 US5403484
 WO9516027
 US5427908
 US5455030
 US5496549
 WO9607754
 EP0710719
 WO9613583
 EP0438474
 US5518889
 EP0463151
 WO9618978
 US5530101
 WO9619256
 US5534621
 US5545806
 US5545807
 US5565362
 US5569825
 WO9634096
 US5571698
 US5576195
 US5580717
 US5580734
 US5582996
 US5585089
 US5595898
 US5601819
 WO9708320
 US5618920
 WO9713852
 US5625126
 US5625825
 US5627052
 US5633425
 US5641670
 US5643759
 US5643768
 US5656730
 US5658754
 US5661016
 US5693762
 US5693493
 US5698435
 US5698417
 EP0814259
 US5714352
 US5723323
 US5733746
 US5733761
 US5750373
 US5763192
 US5763733
 WO9824893
 WO9824884
 US5766886
 US5767260
 US5770428
 US5770359
 US5789650
 US5807706
 US5814476
 US5817483
 US5821333
 US5824514
 US5827690
 US5827739
 US5833985
 WO9850433
 US5837500
 US5839446
 WO9853847
 US5849992
 US5851198
 US5856456
 US5885793
 WO9916419
 US5932448
 US5959084
 US5959083
 WO9954342
 US5976862
 US5989530
 US5994616
 US6010902
 US6019968
 US6037453
 US6060285
 WO0042072
 US6106833
 US6132992
 US6180370
 US6193967
 US6204023
 US6210668
 US2003003097
 WO03011878
 US7935344
 GB19890001334
 GB19910001134
 WO1991US02989
 WO1991GB01134
 WO1991US07149
 GB19920001755
 GB19920002240
 WO1992GB00883
 WO1992GB01755
 WO1993GB00605
 WO1994US01234
 WO1994GB01422
 US19940350260
 WO1994GB02662
 WO1997GB01835
 WO1998US16280
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.